43 minutes · Oct 8, 2018
Christi Shaw, President of Lilly Bio-Medicines, provides a master class on the impact of migraines on the home and the economy. She visited the ICE House for the release of Emgality, a new preventative treatment of migraines in adults and details the journey from medical research breakthrough to FDA approval. Christi shared her thoughts on improving the industry, drug prices, and what she has learned along the way about treating patients and providing value.
Subscribe to episodes
Information contained in this podcast was obtained in part from publicly available sources, and not independently verified. Neither ICE nor its affiliates make any representations or warranties, express or implied, as to the accuracy or completeness of the information and do not sponsor, approve, or endorse any of the content herein, all of which is presented solely for informational and educational purposes. Nothing herein constitutes an offer to sell, a solicitation of an offer to buy any security, or a recommendation of any security or trading practice.